Pneumocystis jirovecii pneumonia after CD4+ T‐cell recovery subsequent to CD19‐targeted chimeric antigen receptor T‐cell therapy: A case report and brief review of literature

BACKGROUND: CD19‐targeted chimeric antigen receptor (CAR)‐T cell therapy involves administration of patient‐derived T cells that target B cells, resulting in B‐cell depletion and aplasia. In immunity against Pneumocystis jirovecii (Pj), CD4+ T cells and, more recently, B cells, are generally conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawata, Kento, Shima, Haruko, Shinjoh, Masayoshi, Yamazaki, Fumito, Kurosawa, Takumi, Yaginuma, Mizuki, Takada, Hiroshi, Shimada, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598253/
https://www.ncbi.nlm.nih.gov/pubmed/37563749
http://dx.doi.org/10.1002/cnr2.1885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598253/
https://www.ncbi.nlm.nih.gov/pubmed/37563749
http://dx.doi.org/10.1002/cnr2.1885

Ejemplares similares